Contents
Current Drug Targets, Volume 9 - Number 5
The Role of Genetics in Inflammatory Bowel Disease
, 9(5): 361 - 368Liesbet Henckaerts, Carolina Figueroa, Severine Vermeire and Miquel Sans
DOI: 10.2174/138945008784221161
Cytokines: From Gut Inflammation to Colorectal Cancer
, 9(5): 375 - 380Massimo C. Fantini and Francesco Pallone
DOI: 10.2174/138945008784221206
Mucosal T Cell Proliferation and Apoptosis in Inflammatory Bowel Disease
, 9(5): 381 - 387Andreas Sturm, Heitor S.P. de Souza and Claudio Fiocchi
DOI: 10.2174/138945008784221198
Immune-non Immune Networks in Intestinal Inflammation
, 9(5): 388 - 394Martin Hausmann and Gerhard Rogler
DOI: 10.2174/138945008784221152
Tolerance in Intestinal Inflammation and Cancer
, 9(5): 404 - 412Marisa Vulcano, Silvio Danese and Antonio Sica
DOI: 10.2174/138945008784221143
New Insights into Inflammatory Bowel Disease Pathophysiology: Paving the Way for Novel Therapeutic Targets
, 9(5): 413 - 418Tommaso Stefanelli, Alberto Malesci, Alessandro Repici, Stefania Vetrano and Silvio Danese
DOI: 10.2174/138945008784221170
Microbial Gut Overgrowth Guarantees Increased Spontaneous Mutation Leading to Polyclonality and Antibiotic Resistance in the Critically Ill
, 9(5): 419 - 421H. K.F. van Saene, N. Taylor, V. Damjanovic and R. E. Sarginson
DOI: 10.2174/138945008784221189
Hypoxia Inducible Factor-1α, Endothelial Progenitor Cells, Monocytes,Cardiovascular Risk, Wound Healing, Cobalt and Hydralazine:A Unifying Hypothesis
, 9(5): 422 - 435Michel R. Hoenig, Cesario Bianchi and Frank W. Sellke
DOI: 10.2174/138945008784221215
Webmaster Contact: info@benthamscience.org